This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing MacroGenics' Recent TAMARACK Phase 2 data for Vobra Duo in mCRPC Patients at ESMO Congress 2024.

Ticker(s): MGNX

Who's the expert?

Institution: Oncology Hematology Associates of West Broward

  • Practicing hematology/oncology for the past 30 years and is currently the President at Oncology and Hematology Associates of West Broward
  • Vice Chief of Staff at Northwest Medical Center and is a Staff Physician with privileges at University Hospital and Medical Center, Broward Health Coral Springs and Florida Medical Center.
  • Familiar with ELVN-001 proof of concept, treats 25 CML patients

Interview Goal
This conversation will focus on the updated efficacy results for Vobra Duo in mCRPC patients.

Are You Interested In These Questions?

Slingshot Insights Explained
2Days Left to Join Project
Call Date
Oct 24, 2024
Call Time
03:00 PM EDT
Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.